Deepinder Goyal, Founder and Group CEO, Eternal said he is personally backing Continue, his longevity venture, with a corpus of Rs 220 crore ($25 million) to support research around human ageing and biology.
“Along with a team of initially skeptical researchers, we've been investigating a penny-drop insight about human aging. Something that's been hiding in plain sight for eternity,” Goyal said in a post on X.
Asked on the purpose behind Continue, Goyal said, “I believe that we have to get lifespans for the general population up to 180+ for real change to happen.”
We are at the tail-end of the research on this hypothesis, which if true, could fundamentally change our understanding of biology and aging, he said.
“Today, we are expanding Continue Research to include a $25 million fund (entirely personally backed) to support researchers across the world who dare to ask simpler questions than anyone else. Who believe biology might be far simpler than we've made it,” Goyal wrote in his post.
Deepinder’s longevity bet
The move to incubate Continue ties in with Goyal’s interest in longevity and extending the lifespan of humans. It will, among other things, focus on mental health and onboard a sleep scientist too, a person familiar with his thinking said.
The ultimate health tracker could eventually become a comprehensive health and wellness platform that will focus on nutrition tracking, sleep tracking, mental health and preventive health.
As it happens, Goyal was an early investor in Ultrahuman, a startup that makes wearables like the Ultrahuman Ring, which helps people measure sleep, heart rate, temperature among other vitals. It also allows people, especially athletes, to track their nutrition and fitness in real time.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
